
Isk Biosciences India Private Limited
Produces and trades crop protection products, deals with chemicals, fertilizers, and compounds.
Produces and trades crop protection products, deals with chemicals, fertilizers, and compounds.
Isk Biosciences India Private Limited (IBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 April 2015 (Nine years and 11 months 7 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 17.50 Cr and a paid-up capital of Rs 17.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Isk Biosciences India Private Limited India is Sweety as COMPANY SECRETARY. Umesh Khaitan, Mikiya Horie, Kiyomitsu Yoshida, and Three other members serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U24100DL2015PTC278699
278699
Private Limited Indian Non-Government Company
06 Apr 2015
13 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ajit Premnath ![]() | Managing Director | 17-Feb-2023 | Current |
Sweety | Company Secretary | 14-Nov-2024 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Umesh Khaitan ![]() | Director | 06-Apr-2015 | Current |
Mikiya Horie ![]() | Director | 08-Aug-2016 | Current |
Kiyomitsu Yoshida ![]() | Director | 05-Oct-2018 | Current |
Shimpei Nemoto ![]() | Director | 27-May-2024 | Current |
Masateru Oguri | Director | 25-Sep-2024 | Current |
Isk Biosciences India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.64% increase. The company also saw a substantial improvement in profitability, with a 966.04% increase in profit. The company's net worth Soared by an impressive increase of 10.02%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Isk Biosciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Umesh Khaitan is a mutual person
Umesh Khaitan is a mutual person
Umesh Khaitan is a mutual person
Umesh Khaitan is a mutual person
Umesh Khaitan is a mutual person
Umesh Khaitan is a mutual person
There are no open charges registered against the company as per our records.
Isk Biosciences India has a workforce of 2 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Isk Biosciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Isk Biosciences India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sweety was appointed as a Company Secretary was appointed as a Company Secretary on 14 Nov 2024 & has been associated with this company since 3 months 28 days .
Masateru Oguri was appointed as a Director was appointed as a Director on 25 Sep 2024 & has been associated with this company since 5 months 17 days .
Isk Biosciences India Private Limited last Annual general meeting of members was held on 13 Sep 2024 as per latest MCA records.
Shimpei Nemoto was appointed as a Director was appointed as a Director on 27 May 2024 & has been associated with this company since 9 months 16 days .
Isk Biosciences India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Kiyomitsu Yoshida was appointed as a Director was appointed as a Director on 05 Oct 2018 & has been associated with this company since 6 years 5 months .
Isk Biosciences India Private Limited was incorporated on 06 Apr 2015.
The authorized share capital of Isk Biosciences India Private Limited is ₹ 17.50 Cr and paid-up capital is ₹ 17.50 Cr.
Currently 7 directors are associated with Isk Biosciences India Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Isk Biosciences India Private Limited is Unit No 901 9Th Floor Eros Corporate Tower, Nehru Place India, New Delhi, 110019.
The corporate identification number (CIN) of Isk Biosciences India Private Limited is U24100DL2015PTC278699 and the company number is 278699 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Isk Biosciences India Private Limited has risen by 31.64%.
As Per 2023 financial reports, 2 employees are currently employed by Isk Biosciences India Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Isk Biosciences India Private Limited has experienced an upsurge of 10.02%.
The most recent Balance Sheet for Isk Biosciences India Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
HY
CH
KM
TS